Op-brai130150 1..12
نویسندگان
چکیده
1 Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, University College London, WC1N 3BG, London, UK 2 Department of Neurology, University of Ljubljana, 1000 Ljubljana, Slovenia 3 Unidad de Trastornos del Movimiento, Servicio de Neurologı́a y Neurofisiologı́a Clı́nica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocı́o/CSIC/Universidad de Sevilla, 41013 Seville, Spain 4 Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas CIBERNED, 41013 Seville, Spain
منابع مشابه
Lab Assignments
Lab Assignments Instrumentation Labs: Name of Lab Assignment: Lab 1 Introductory Experiments and Linear Circuits I [1] Lab 2 Linear Circuits II [2] Lab 3 Semiconductor Diodes [3] Lab 4 JFET Circuits I [4] Lab 5 JFET Circuits II [5] Lab 6 Op Amps I [6] Lab 7 Op Amps II [7] Lab 8 Op Amps III [8] Lab 9 LabVIEW Programming [9] Lab 10 Analog to Digital and Digital to Analog Conversion [10] Lab 11 Si...
متن کاملLab Assignments
Lab Assignments Instrumentation Labs: Name of Lab Assignment: Lab 1 Introductory Experiments and Linear Circuits I [1] Lab 2 Linear Circuits II [2] Lab 3 Semiconductor Diodes [3] Lab 4 JFET Circuits I [4] Lab 5 JFET Circuits II [5] Lab 6 Op Amps I [6] Lab 7 Op Amps II [7] Lab 8 Op Amps III [8] Lab 9 LabVIEW Programming [9] Lab 10 Analog to Digital and Digital to Analog Conversion [10] Lab 11 Si...
متن کاملOsteogenic protein 1 device increases bone formation and bone graft resorption around cementless implants.
In each femoral condyle of 8 Labrador dogs, a non weight-bearing hydroxyapatite-coated implant was inserted surrounded by a 3 mm gap. Each gap was filled with bone allograft or ProOsteon with or without OP-1 delivered in a bovine collagen type I carrier (OP-1 device). 300 microg OP-1 was used in the 0.75 cc gap surrounding the implant. After 3 weeks, the OP-1 device enhanced implant fixation by...
متن کاملHigh doses of vascular endothelial growth factor 165 safely, but transiently, improve myocardial perfusion in no-option ischemic disease.
UNLABELLED Gene therapy can induce angiogenesis in ischemic tissues. The aim of this study was to assess safety, feasibility, and results, both clinical and on myocardial perfusion, of gene therapy in refractory angina. This was a phase I/II, prospective, temporal-controlled series, clinical trial. Thirteen patients were maintained for minimum 6 months under optimized clinical management, and t...
متن کامل